JP2023520410A5 - - Google Patents
Info
- Publication number
- JP2023520410A5 JP2023520410A5 JP2022559601A JP2022559601A JP2023520410A5 JP 2023520410 A5 JP2023520410 A5 JP 2023520410A5 JP 2022559601 A JP2022559601 A JP 2022559601A JP 2022559601 A JP2022559601 A JP 2022559601A JP 2023520410 A5 JP2023520410 A5 JP 2023520410A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cell
- sequence shown
- scfv
- sequence number
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003213P | 2020-03-31 | 2020-03-31 | |
| US63/003,213 | 2020-03-31 | ||
| PCT/US2021/025248 WO2021202793A2 (en) | 2020-03-31 | 2021-03-31 | Chimeric antigen receptors targeting cd33 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026077011A Division JP2026129856A (ja) | 2020-03-31 | 2026-04-30 | Ｃｄ３３を標的にするキメラ抗原受容体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520410A JP2023520410A (ja) | 2023-05-17 |
| JP2023520410A5 true JP2023520410A5 (enExample) | 2024-03-28 |
| JP7859985B2 JP7859985B2 (ja) | 2026-05-15 |
Family
ID=77929884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559601A Active JP7859985B2 (ja) | 2020-03-31 | 2021-03-31 | Ｃｄ３３を標的にするキメラ抗原受容体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230151094A1 (enExample) |
| EP (1) | EP4126925A4 (enExample) |
| JP (1) | JP7859985B2 (enExample) |
| CN (1) | CN115335396A (enExample) |
| CA (1) | CA3173210A1 (enExample) |
| WO (1) | WO2021202793A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7840865B2 (ja) | 2020-03-31 | 2026-04-06 | フレッド ハッチンソン キャンサー センター | キメラ抗原受容体ターゲティングｃｄ３３ |
| WO2024037461A1 (zh) * | 2022-08-16 | 2024-02-22 | 赛斯尔擎生物技术（上海）有限公司 | 工程化免疫细胞及其制备方法 |
| WO2025059062A1 (en) * | 2023-09-11 | 2025-03-20 | The Trustees Of The University Of Pennsylvania | Genetic engineering of human hematopoietic stem/progenitor cells (hspcs) for locus-specific expression of therapeutic proteins |
| CN120177299B (zh) * | 2024-12-03 | 2026-06-12 | 江苏省人民医院（南京医科大学第一附属医院） | 利用流式细胞仪识别慢性粒单核细胞免疫分型的抗体组合物及方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2765710T3 (es) * | 2014-04-03 | 2020-06-10 | Cellectis | Receptores de antígeno quimérico específicos de CD33 para la inmunoterapia del cáncer |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| GB201518136D0 (en) * | 2015-10-14 | 2015-11-25 | Glaxosmithkline Ip Dev Ltd | Novel chimeric antigen receptors |
| JP7189019B2 (ja) * | 2016-02-05 | 2022-12-13 | シティ・オブ・ホープ | 中枢神経系の癌の治療のための操作されたｔ細胞の投与 |
| US20190233534A1 (en) * | 2016-07-14 | 2019-08-01 | Fred Hutchinson Cancer Research Center | Multiple bi-specific binding domain constructs with different epitope binding to treat cancer |
| WO2018218207A1 (en) | 2017-05-26 | 2018-11-29 | Fred Hutchinson Cancer Research Center | Anti-cd33 antibodies and uses thereof |
| WO2019084234A1 (en) * | 2017-10-26 | 2019-05-02 | St. Jude Childen's Research Hospital, Inc. | METHODS AND COMPOSITIONS FOR TREATING CD33 + CANCERS AND IMPROVING IN VIVO PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR T CELLS |
| CN109970862A (zh) * | 2017-12-27 | 2019-07-05 | 亘喜生物科技（上海）有限公司 | 一种携带Beacon标签的嵌合抗原受体T细胞改造技术 |
| US20210017277A1 (en) * | 2018-03-14 | 2021-01-21 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Anti-cd33 chimeric antigen receptors and their uses |
| JOP20190116A1 (ar) * | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
| WO2019246593A2 (en) * | 2018-06-22 | 2019-12-26 | Fred Hutchinson Cancer Research Center | Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders |
-
2021
- 2021-03-31 EP EP21780312.1A patent/EP4126925A4/en active Pending
- 2021-03-31 WO PCT/US2021/025248 patent/WO2021202793A2/en not_active Ceased
- 2021-03-31 CN CN202180025378.5A patent/CN115335396A/zh active Pending
- 2021-03-31 JP JP2022559601A patent/JP7859985B2/ja active Active
- 2021-03-31 US US17/995,085 patent/US20230151094A1/en active Pending
- 2021-03-31 CA CA3173210A patent/CA3173210A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6909844B2 (ja) | 細胞 | |
| US12048718B2 (en) | Chimeric antigen receptor and CAR-T cells that bind BCMA | |
| JP7745616B2 (ja) | 腫瘍特異的Ｔ細胞免疫療法用のＩＬ－１３受容体α２（ＩＬ１３Ｒα２）標的キメラ抗原受容体 | |
| CN112074278B (zh) | Bcma-car-t细胞 | |
| JP2009502171A5 (enExample) | ||
| CN110382539B (zh) | 用于cd16a定向的nk细胞结合的串联双抗体 | |
| CN106459213B (zh) | 修饰的j链 | |
| DK2900694T3 (en) | BISPECIFIC IGG ANTIBODIES AS T-CELL ACTIVATORS | |
| JP2022506598A5 (enExample) | ||
| TWI373475B (en) | Recombinant triplex scaffold-based polypeptides | |
| JP2016520074A5 (enExample) | ||
| JP2018523485A5 (enExample) | ||
| JP2022512882A5 (enExample) | ||
| JP2022516389A5 (enExample) | ||
| JP2019537433A5 (enExample) | ||
| JP2021518108A5 (enExample) | ||
| JP2021514193A5 (enExample) | ||
| JP2022547416A5 (enExample) | ||
| CN118843693A (zh) | 靶向bcma的嵌合抗原受体及其应用 | |
| JP2022527081A5 (enExample) | ||
| JP2020532969A5 (enExample) | ||
| JP2022544075A5 (enExample) | ||
| CN111093702A (zh) | 靶细胞依赖性T细胞的接合和活化型不对称异二聚Fc-ScFv融合抗体形式用于癌症治疗 | |
| JP2022548112A5 (enExample) | ||
| JP2023520409A5 (enExample) |